4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0000950170-24-071537
10% owner acquired 7,520,667 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. 10% owner | 2024-06-10 | Conversion | +6,551,449 | 7,135,233 | D | ||
| Third Rock Ventures V, L.P. 10% owner | 2024-06-10 | Conversion | +969,218 | 969,218 | I | ||
| Derivatives | |||||||
| Third Rock Ventures V, L.P. 10% owner | 2024-06-10 | Conversion · Series A Preferred Stock | −56,091,177 | 0 | D | ||
| Third Rock Ventures V, L.P. 10% owner | 2024-06-10 | Conversion · Series A Preferred Stock | −8,000,000 | 0 | I | ||
| Third Rock Ventures V, L.P. 10% owner | 2024-06-10 | Conversion · Series B Preferred Stock | −298,103 | 0 | I | ||
Loading xslF345X05/ownership.xml…